Загрузка...
Polyvalent pneumococcal polysaccharide vaccines
A 14-valent pneumococcal vaccine has recently been licensed for general use after extensive testing in human subjects. Antibody production was satisfactory in 92% of individuals and a highly significant (76-92%) reduction was found in the rates for pneumococcal pneumonias caused by the capsular type...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
1978
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2395578/ https://ncbi.nlm.nih.gov/pubmed/28857 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|